Clinical Trials Logo
  1. Home
  2. Mouth Neoplasms
  3. NCT02604121

Cytological Screening for Early Diagnosis of Precancerous or Cancerous Lesions of Oral Cavity — Cytobuccale  

Mouth Neoplasms Clinical Trial

Official title:
Interest of Cytological Screening for Early Diagnosis of Precancerous or Cancerous Lesions of Oral Cavity by Transepithelial Brushing in Liquid-based

Clinical Trial Summary

Prospective study of diagnosis validation of a cytological technique. 200 patients with oral cavity cancerous and precancerous lesions will be enrolled.

A cytological sample of the lesion will be performed by transepithelial brushing ( Orcellex® Rovers brush) in cytology liquid-based technology (methode ThinPrep 2000 (Hologic®)). A microscopic double blind reading will be performed. A biopsy sampling will be carried out in accordance with current strategy of screening. The brushing diagnosis quality will be compared to the biopsy which is the gold standard.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02604121
Study type Interventional
Source University Hospital, Toulouse
Contact
Status Completed
Phase N/A
Start date February 2013
Completion date February 2019
View Details
See also
  Status Clinical Trial Phase
Terminated NCT01216020 - Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck Cancer Phase 2
Completed NCT00953849 - Vitamin D - Celecoxib Therapy Phase 1/Phase 2
Completed NCT01649349 - The Feasibility Study of Dual-Section Nasogastric Tube Phase 0
Completed NCT00721799 - F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients Phase 2
Recruiting NCT00193843 - Oral Cancer Adjuvant Therapy (OCAT) Trial Phase 3
Completed NCT04009811 - A New Membrane Obturator Prothesis Concept for Soft Palate Defects N/A
Terminated NCT00272181 - Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer Phase 2
Completed NCT01553851 - GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell Cancer Phase 2
Recruiting NCT02290145 - Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at Clinical N2 Stage Phase 2
Terminated NCT00412776 - Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer Phase 2/Phase 3
Completed NCT06231537 - Visual Oral Examination for Early Detection of Oral Cancer in High-Risk Individuals N/A
Recruiting NCT02285530 - GDF15 Based TPF Induction Chemotherapy for OSCC Patients Phase 2
Terminated NCT02285543 - A Phase II Trial of TPF Induction Chemotherapy in cN2 OSCC Patients Phase 2
Active, not recruiting NCT00341497 - Biomarkers for Oral Cancer
Completed NCT01195922 - Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma Phase 1/Phase 2
Recruiting NCT05296941 - Oral Cancer Screening for Early Detection of Premalignant Disorders (PMOD) N/A
Not yet recruiting NCT05774483 - Sentinel Node Biopsy Versus Limited Elective Neck Dissection in Early Cancers of Oral Cavity NoDe Negative N/A
Completed NCT01104714 - Pharmacogenetic Response to Chemotherapy Induction for ORL Cancers N/A